Latest generation LUCAS™2 Chest Compression System approved for sales in Japan
April 8, 2010, Lund, Sweden
Jolife AB today announced that its latest generation LUCAS™2 Chest Compression System received SHONIN approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) on the 2nd of April. The LUCAS™2 Chest Compression System is a medical device that assists rescuers in providing chest compressions during cardiopulmonary resuscitation (CPR) to maintain life-sustaining blood flow in cardiac arrest patients.
The second generation LUCAS™2 builds upon the well-proven LUCAS™1 technology, but with a change of driving source from pneumatic to electric. LUCAS™2 may be operated either on battery alone or in combination with wall or car electricity outlets. The lightweight and compact unit is easy to carry and store, and incorporates new features such as alerts and pauses to aid ventilation during compressions, a softer start at adjustment to the patient’s chest and a quieter operation.
LUCAS™2 will, in addition to the already approved LUCAS™1, be marketed and sold to hospitals and emergency medical services in Japan exclusively by Physio-Control Japan, a division of Medtronic Inc., which is a leader in manufacturing and marketing of defibrillators. There are close to 5000 ambulances and 9000 hospitals in Japan.
The LUCAS™ Chest Compression Systems are currently marketed in 34 countries around the world, and an estimated 25 000 patients have been treated with LUCAS™CPR so far.
LUCAS™Chest Compression System is an easy-to-use and lightweight device that provides quality chest compressions according to the European Resuscitation Council and American Heart Association Guidelines for CPR (cardiopulmonary resuscitation). It assists rescuers in maintaining vital blood circulation in cardiac arrest patients. LUCAS™ is simple to use, applied within seconds and feasible for use in a majority of cardiac arrest patients. LUCAS™ is available in an electrically driven version (LUCAS™2) and a pneumatically driven (LUCAS™1). The mechanical CPR device has shown to increase operational efficacy and to improve the opportunities to save cardiac arrest patients.
About Jolife AB
Jolife AB, founded in 2000, develops and manufactures the LUCAS™ Chest Compression System. Jolife works closely with leading physicians, nurses, paramedics and first responders and is committed to research and development in order to continue to offer innovative products. The LUCAS™ Chest Compression Systems are sold on the major markets in the world, including US, Canada, Japan and Europe. Based in Lund in southern Sweden, Jolife markets its products through an exclusive global distribution agreement with Physio-Control, Inc., a division of Medtronic Inc. – except in Sweden, Norway and Finland, where Jolife sells directly.